intravitreal bevacizumab vs. combination of intravitreal bevacizumab plus macular photocoagulation in clinically significant diabetic macular edema: 6 months results of a randomized clinical trial

نویسندگان

هوشنگ فقیهی

hooshang faghihi محمد ریاضی اصفهانی

mohammad riazi esfahani زهرا اعلمی هرندی

zahra aalami harandi شهرام مدنی

shahram madani

چکیده

purpose : to compare the 6-months anatomic and best corrected visual acuity (bcva) responses after primary intravitreal bevacizumab (ivb intravitreal avastin) and ivb plus macular photocoagulation (mpc) in diabetics with clinically significant macular edema (csme) methods : in this interventional randomized clinical trial (rct) 40 diabetics (80 eyes) with bilateral csme and non-proliferative diabetic retinopathy (npdr) or early proliferative diabetic retinopathy (pdr) underwent ivb in one eye (group a) and ivb plus mpc in the other eye (group a+mpc). the patients had a complete eye exam (including bcva, oct and fluorescein angiography (f/a)) at baseline and were re-examined every two months for 6 months bcva and oct indices and number of ivb injections were recorded. main outcome measures were number of ivb injections and changes in bcva and oct. results : in both groups, the mean bcva [(group a: 0.326±0.279 logmar±sd before treatment and 0.188±0.245 logmar±sd at 6 months), (group a+ mpc 0.409±0.332 logmar±sd baseline and 0.230±0.273 logmar±sd at 6 months)] and oct indices [(group a: 261±115 µ before treatment and 221±87 µ mean±sd at 6 months) , (group a+ mpc: 270±93 µ baseline and 225±80 µ mean±sd at 6 months)] improved at the final follow-up and these changes were statistically significant however there was no significant difference between the two groups at baseline and the final visit at 6 months follow-up. there was also no statistically significant difference in number of ivb injections between the two groups (group a: 2.3±1.24 and group a± mpc: 2.49±1.09). conclusion : ivb injection is an effective modality of treatment in csme, but mpc appears to have no additive effect on it, at least in the first 6 months of treatment.    iranian journal of ophthalmology 201022(1):21-26 © 2010 by the iranian society of ophthalmology

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.

PURPOSE To evaluate the additive effect of triamcinolone to bevacizumab in comparison to standard macular laser photocoagulation versus bevacizumab in the management of diabetic macular edema (DME). METHODS In a prospective, randomized clinical trial, 130 eyes of 110 patients with type 2 diabetes with DME were included. Eligible eyes were randomly assigned to 1.25 mg intravitreal bevacizumab ...

متن کامل

Improvement of Diabetic Macular Edema in the Fellow Eye After Monocular Intravitreal Bevacizumab Injection

Introduction: Because of bilateral involvement in many cases with diabetic macular edema, Intravitreal bevacizumab injection perform in both eyes. There are some reports of therapeutic effects in the fellow eye after monocular injection of anti-vascular endothelial growth factors. In this study we describe a case of bilateral improvement of diabetic macular edema following unil...

متن کامل

randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema

purpose: to compare the results of intravitreal bevacizumb (ivb) injection alone or in combination with intravitreal triamcinolone acetonide (ivt) versus macular laser photocoagulation (mpc) as primary treatment of diabetic macular edema (dme). methods: in this randomized clinical trial, 150 eyes of 129 patients with clinical dme and no previous treatment were enrolled. the eyes were randomly a...

متن کامل

Comparison of Intravitreal Injection of Bevacizumab and Triamcinolone Acetonide in the Treatment of Uveitic Macular Edema

Background: Cystoid Macular Edema (CME) is one of the most common and sight threatening complications of uveitis. Intravitreal injection of corticosteroids and anti-VEGF antibody are two routine options for treatment. Objective: To compare the effects of intravitreal injections of Bevacizumab and Triamcinolone Acetonide for the treatment of persistent macular edema in non-infectious uveitis. Me...

متن کامل

Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.

PURPOSE To compare the results of intravitreal bevacizumab (IVB) injection alone or in combination with intravitreal triamcinolone acetonide (IVT) versus macular laser photocoagulation (MPC) as a primary treatment of diabetic macular edema (DME). DESIGN Randomized 3-arm clinical trial. PARTICIPANTS A total of 150 eyes of 129 patients with clinically significant DME and no previous treatment...

متن کامل

Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.

PURPOSE To evaluate the efficacy of intravitreal injection of bevacizumab (IVB) followed by modified grid laser photocoagulation (MGP) versus each alone as a primary treatment of diffuse diabetic macular edema. PATIENTS AND METHODS A randomized 3-arm clinical trial in which 62 eyes of 48 patients with diffuse diabetic macular edema were enrolled. Eyes were randomly distributed to 1 of 3 study...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
journal of current ophthalmology

جلد ۲۲، شماره ۱، صفحات ۲۱-۲۶

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023